FIELD: biotechnology.
SUBSTANCE: group of inventions is described, including an antibody or its antigen-binding fragment that binds IX Padua factor, polypeptide that binds IX Padua factor, a conjugate that binds IX Padua factor, containing the above-mentioned antibody or antigen-binding fragment, or polypeptide, nucleic acid, an expression vector, a host cell, a kit for the detection of IX Padua factor, a composition for the detection of IX Padua factor (options), use of antibodies or an antigen-binding fragment, polypeptide, a conjugate, nucleic acid, a vector, a host cell and a kit for the detection of IX Padua factor in a sample, and a method for the detection of IX Padua factor in a sample obtained from a subject. In one of embodiments, the antibody or its antigen-binding fragment contains an amino acid sequence SSYAIS (SEQ ID NO: 6); GIVPAFGTANYAQKFQG (SEQ ID NO: 7); SWGVISFAY (SEQ ID NO: 8); RASQDISSYLN (SEQ ID NO: 9); AASNLQS (SEQ ID NO: 10); and MQYDSLPFTF (SEQ ID NO: 11).
EFFECT: invention expands the arsenal of means for binding IX Padua factor.
49 cl, 32 dwg, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PROCOAGULANT ANTIBODIES | 2018 |
|
RU2810094C2 |
ADVANCED PROCOAGULANT ANTIBODIES | 2019 |
|
RU2810748C2 |
MULTI-SPECIFIC ANTIGEN-BINDING MOLECULE HAVING SUBSTITUTE FUNCTIONAL ACTIVITY OF BLOOD COAGULATING FACTOR VIII CO-FACTOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SPECIFIED MOLECULE AS ACTIVE INGREDIENT | 2018 |
|
RU2812909C2 |
DOSING REGIMEN FOR TFPI ANTAGONISTS | 2019 |
|
RU2780590C1 |
BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3 | 2018 |
|
RU2778805C2 |
ANTIBODIES AGAINST XI CLOTTING FACTOR | 2017 |
|
RU2757314C2 |
MODIFIED FACTOR IX, AS WELL AS COMPOSITIONS, METHODS AND OPTIONS FOR THE USE OF GENE TRANSFER INTO CELLS, ORGANS AND TISSUE | 2016 |
|
RU2811445C2 |
COMBINATIONS OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS | 2019 |
|
RU2804815C2 |
DISPLAY OF AN INTEGRAL MEMBRANE PROTEIN ON EXTRACELLULAR ENVELOPED POXVIRUS VIRIONS | 2017 |
|
RU2759846C2 |
TETANUS TOXIN ANTIBODY AND USE THEREOF | 2020 |
|
RU2815280C1 |
Authors
Dates
2022-04-14—Published
2017-05-16—Filed